High-potency cannabis use predicted psychosis risk independently of genetic predisposition
Daily use of high-potency cannabis carried a 5-fold increased risk of psychotic disorder regardless of genetic predisposition to schizophrenia, and genetic risk did not predict heavy cannabis use, challenging the idea that genetics alone explain the cannabis-psychosis link.
Quick Facts
What This Study Found
In the EU-GEI study, daily use of high-potency cannabis had OR 5.09 (95% CI 3.08-8.43) for psychotic disorder even after adjusting for schizophrenia polygenic risk score (PRS). Schizophrenia PRS was not associated with cannabis use patterns in cases or controls. No interaction between PRS and cannabis use was found.
Key Numbers
EU-GEI: 1,098 participants. UK Biobank: 143,600 participants. Daily high-potency cannabis adjusted OR: 5.09 (95% CI 3.08-8.43, p=3.21x10^-10). No significant PRS x cannabis use interaction.
How They Did This
Two datasets: EU-GEI case-control study (1,098 participants) and UK Biobank (143,600 participants). Schizophrenia and cannabis use disorder polygenic risk scores calculated from GWAS data. Cannabis use patterns assessed and interaction with PRS tested.
Why This Research Matters
A common counterargument to the cannabis-psychosis link is that shared genetics explain both. This study found that genetic predisposition to schizophrenia did not predict heavy cannabis use, and high-potency cannabis was a strong independent risk factor.
The Bigger Picture
These findings from two large datasets strengthen the case that high-potency cannabis is an independent environmental risk factor for psychosis. As cannabis potency continues to rise globally, this has direct public health implications.
What This Study Doesn't Tell Us
Observational design cannot prove causation despite controlling for genetic confounding. Cannabis potency was self-reported. PRS captures only a fraction of genetic risk for schizophrenia. Different assessment methods across the two datasets.
Questions This Raises
- ?Would reducing available cannabis potency decrease population-level psychosis rates?
- ?Is there a potency threshold below which psychosis risk is minimal?
- ?Do these findings apply to newer, extremely high-potency concentrates?
Trust & Context
- Key Stat:
- OR 5.09 for daily high-potency use
- Evidence Grade:
- Two large-scale datasets with genetic controls provide strong evidence, though observational design cannot fully establish causation.
- Study Age:
- 2024 analysis of EU-GEI and UK Biobank data
- Original Title:
- The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.
- Published In:
- Psychological medicine, 54(15), 1-13 (2024)
- Authors:
- Austin-Zimmerman, Isabelle(10), Spinazzola, Edoardo(11), Quattrone, Diego(18), Wu-Choi, Beatrice, Trotta, Giulia, Li, Zhikun, Johnson, Emma, Richards, Alexander L, Freeman, Tom P, Tripoli, Giada, Gayer-Anderson, Charlotte, Rodriguez, Victoria, Jongsma, Hannah E, Ferraro, Laura, La Cascia, Caterina, Tosato, Sarah, Tarricone, Ilaria, Berardi, Domenico, Bonora, Elena, Seri, Marco, D'Andrea, Giuseppe, Szöke, Andrei, Arango, Celso, Bobes, Julio, Sanjuán, Julio, Santos, Jose Luis, Arrojo, Manuel, Velthorst, Eva, Bernardo, Miguel, Del-Ben, Cristina Marta, Rossi Menezes, Paulo, Selten, Jean-Paul, Jones, Peter B, Kirkbride, James B, Rutten, Bart P F, Tortelli, Andrea, Llorca, Pierre-Michel, de Haan, Lieuwe, Stilo, Simona, La Barbera, Daniele, Lasalvia, Antonio, Schurnhoff, Franck, Pignon, Baptiste, van Os, Jim, Lynskey, Michael, Morgan, Craig, O' Donovan, Michael, Lewis, Cathryn M, Sham, Pak C, Murray, Robin M, Vassos, Evangelos, Di Forti, Marta
- Database ID:
- RTHC-05096
Evidence Hierarchy
Frequently Asked Questions
Does genetic predisposition to schizophrenia make people use more cannabis?
This study found schizophrenia polygenic risk was not associated with cannabis use patterns in most analyses. A weak association in UK Biobank participants without psychosis disappeared when cannabis use disorder genetics were accounted for.
How much does high-potency cannabis increase psychosis risk?
Daily use of high-potency cannabis was associated with a 5-fold increased odds of psychotic disorder, even after accounting for genetic predisposition to schizophrenia.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-05096APA
Austin-Zimmerman, Isabelle; Spinazzola, Edoardo; Quattrone, Diego; Wu-Choi, Beatrice; Trotta, Giulia; Li, Zhikun; Johnson, Emma; Richards, Alexander L; Freeman, Tom P; Tripoli, Giada; Gayer-Anderson, Charlotte; Rodriguez, Victoria; Jongsma, Hannah E; Ferraro, Laura; La Cascia, Caterina; Tosato, Sarah; Tarricone, Ilaria; Berardi, Domenico; Bonora, Elena; Seri, Marco; D'Andrea, Giuseppe; Szöke, Andrei; Arango, Celso; Bobes, Julio; Sanjuán, Julio; Santos, Jose Luis; Arrojo, Manuel; Velthorst, Eva; Bernardo, Miguel; Del-Ben, Cristina Marta; Rossi Menezes, Paulo; Selten, Jean-Paul; Jones, Peter B; Kirkbride, James B; Rutten, Bart P F; Tortelli, Andrea; Llorca, Pierre-Michel; de Haan, Lieuwe; Stilo, Simona; La Barbera, Daniele; Lasalvia, Antonio; Schurnhoff, Franck; Pignon, Baptiste; van Os, Jim; Lynskey, Michael; Morgan, Craig; O' Donovan, Michael; Lewis, Cathryn M; Sham, Pak C; Murray, Robin M; Vassos, Evangelos; Di Forti, Marta. (2024). The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.. Psychological medicine, 54(15), 1-13. https://doi.org/10.1017/S0033291724002058
MLA
Austin-Zimmerman, Isabelle, et al. "The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.." Psychological medicine, 2024. https://doi.org/10.1017/S0033291724002058
RethinkTHC
RethinkTHC Research Database. "The impact of schizophrenia genetic load and heavy cannabis ..." RTHC-05096. Retrieved from https://rethinkthc.com/research/austin-zimmerman-2024-the-impact-of-schizophrenia
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.